$OPK
OPKO HEALTH, INC.

2013 Q4 Form 10-Q Financial Statement

#000094480913000009 Filed on November 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $20.69M $20.64M $11.80M
YoY Change 27.25% 75.0% 73.46%
Cost Of Revenue $12.00M $11.95M $7.487M
YoY Change 34.83% 59.64% 87.18%
Gross Profit $56.56M $39.65M $21.16M
YoY Change 117.75% 87.36% 655.82%
Gross Profit Margin 273.33% 192.09% 179.42%
Selling, General & Admin $15.40M $13.57M $7.322M
YoY Change 48.08% 85.36% 70.28%
% of Gross Profit 27.23% 34.23% 34.6%
Research & Development $23.40M $11.09M $3.621M
YoY Change 254.55% 206.13% 9.73%
% of Gross Profit 41.37% 27.96% 17.11%
Depreciation & Amortization $4.600M $3.768M $2.665M
YoY Change 64.29% 41.39% 142.27%
% of Gross Profit 8.13% 9.5% 12.59%
Operating Expenses $56.56M $39.65M $21.16M
YoY Change 230.75% 87.35% 146.09%
Operating Profit $0.00 -$19.01M -$9.646M
YoY Change -100.0% 97.08% 66.31%
Interest Expense -$1.100M -$40.80M -$300.0K
YoY Change -222.22% 13500.0% 0.0%
% of Operating Profit
Other Income/Expense, Net $22.60M -$38.90M -$120.0K
YoY Change -2154.55% 32317.5% -70.0%
Pretax Income -$14.40M -$57.91M -$9.489M
YoY Change 44.0% 510.3% 45.98%
Income Tax -$600.0K $1.290M -$128.0K
% Of Pretax Income
Net Earnings -$17.43M -$60.00M -$9.646M
YoY Change 3385.8% 522.0% 17.63%
Net Earnings / Revenue -84.23% -290.67% -81.78%
Basic Earnings Per Share
Diluted Earnings Per Share -$41.02K -$166.4K -$32.20K
COMMON SHARES
Basic Shares Outstanding 408.0M shares 336.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $185.8M $180.8M $42.40M
YoY Change 578.1% 326.42% -51.49%
Cash & Equivalents $185.8M $155.8M $23.43M
Short-Term Investments $25.00M $18.90M
Other Short-Term Assets $5.653M $4.304M $5.000M
YoY Change 19.01% -13.92% -28.57%
Inventory $18.08M $19.52M $21.50M
Prepaid Expenses
Receivables $19.77M $21.37M $19.10M
Other Receivables $0.00 $6.800M $0.00
Total Short-Term Assets $242.7M $241.3M $88.00M
YoY Change 208.59% 174.18% -25.17%
LONG-TERM ASSETS
Property, Plant & Equipment $17.03M $17.03M $12.80M
YoY Change 8.42% 33.02% 287.88%
Goodwill $226.4M $222.3M
YoY Change 181.38%
Intangibles
YoY Change
Long-Term Investments $30.70M $23.10M $15.00M
YoY Change 96.79% 54.0% 154.24%
Other Assets $6.861M $7.003M $1.900M
YoY Change 147.07% 268.58% -50.0%
Total Long-Term Assets $1.149B $1.142B $162.0M
YoY Change 444.0% 604.76% 385.03%
TOTAL ASSETS
Total Short-Term Assets $242.7M $241.3M $88.00M
Total Long-Term Assets $1.149B $1.142B $162.0M
Total Assets $1.392B $1.383B $250.0M
YoY Change 380.11% 453.19% 65.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.41M $13.63M $7.200M
YoY Change 31.51% 89.32% 176.92%
Accrued Expenses $65.87M $43.27M $21.80M
YoY Change 167.17% 98.48% 489.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $12.56M $14.48M $17.40M
YoY Change -28.32% -16.8% 39.2%
Total Short-Term Liabilities $91.85M $71.38M $46.40M
YoY Change 75.35% 53.83% 129.7%
LONG-TERM LIABILITIES
Long-Term Debt $3.270M $3.350M $4.000M
YoY Change -36.5% -16.25%
Other Long-Term Liabilities $214.8M $234.8M $18.10M
YoY Change 528.59% 1197.03%
Total Long-Term Liabilities $426.7M $443.7M $22.10M
YoY Change 1148.79% 1907.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $91.85M $71.38M $46.40M
Total Long-Term Liabilities $426.7M $443.7M $22.10M
Total Liabilities $518.5M $515.1M $79.40M
YoY Change 499.12% 548.69% 254.46%
SHAREHOLDERS EQUITY
Retained Earnings -$503.2M -$486.4M
YoY Change 29.43%
Common Stock $4.148M $4.089M
YoY Change 35.73%
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.362M $7.457M
YoY Change -1.27%
Treasury Stock Shares 2.264M shares 2.293M shares
Shareholders Equity $876.4M $870.7M $170.7M
YoY Change
Total Liabilities & Shareholders Equity $1.392B $1.383B $250.0M
YoY Change 380.11% 453.19% 65.56%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$17.43M -$60.00M -$9.646M
YoY Change 3385.8% 522.0% 17.63%
Depreciation, Depletion And Amortization $4.600M $3.768M $2.665M
YoY Change 64.29% 41.39% 142.27%
Cash From Operating Activities -$26.10M -$8.900M -$1.900M
YoY Change 357.89% 368.42% -42.42%
INVESTING ACTIVITIES
Capital Expenditures -$1.000M -$900.0K -$700.0K
YoY Change 150.0% 28.57% 0.0%
Acquisitions
YoY Change
Other Investing Activities $39.90M $46.20M -$10.10M
YoY Change 353.41% -557.43% -178.91%
Cash From Investing Activities $38.90M $45.20M -$10.80M
YoY Change 363.1% -518.52% -189.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 17.00M 300.0K -1.800M
YoY Change 1600.0% -116.67% 1700.0%
NET CHANGE
Cash From Operating Activities -26.10M -8.900M -1.900M
Cash From Investing Activities 38.90M 45.20M -10.80M
Cash From Financing Activities 17.00M 300.0K -1.800M
Net Change In Cash 29.80M 36.60M -14.50M
YoY Change 705.41% -352.41% -266.67%
FREE CASH FLOW
Cash From Operating Activities -$26.10M -$8.900M -$1.900M
Capital Expenditures -$1.000M -$900.0K -$700.0K
Free Cash Flow -$25.10M -$8.000M -$1.200M
YoY Change 373.58% 566.67% -53.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3818000 USD
CY2012Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
886000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
13631000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10200000 USD
CY2012Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
21636000 USD
CY2013Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
22506000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21162000 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21372000 USD
CY2012Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3319000 USD
CY2013Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
6416000 USD
CY2013Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3225000 USD
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1614000 USD
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
43269000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24656000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
675000 USD
CY2013Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7203000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3237000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7356000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
565201000 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1357235000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7411000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
474000 USD
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1134000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
993000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6277000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8192000 USD
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2178000 USD
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2790000 USD
CY2012Q4 us-gaap Assets
Assets
289830000 USD
CY2013Q3 us-gaap Assets
Assets
1382982000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
241277000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
78657000 USD
CY2013Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
31455000 USD
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
12148000 USD
CY2013Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
29005000 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
5335000 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
10800000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23428000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-48088000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
128473000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-43864000 USD
CY2012Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-15745000 USD
CY2013Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-75858000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
130118000 USD
CY2013Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
20641000 USD
CY2012Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
13976000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
37327000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
75838000 USD
CY2013Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
252000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4173000 USD
CY2012Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
556000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2665000 USD
CY2012Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
20000000 USD
CY2013Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
69200000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155834000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27361000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71516000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
14000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
305560763 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
408903912 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
3056000 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
4089000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7924000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-102146000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22083000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59591000 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
24386000 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2012Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2013Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
208917000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
36812000 USD
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11952000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19028000 USD
CY2012Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7487000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2013Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.03
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-197000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
1900000 USD
CY2013Q3 us-gaap Deferred Revenue
DeferredRevenue
7900000 USD
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7040000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1518000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
164892000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9777000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10648000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7447000 USD
CY2012Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2665000 USD
CY2013Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3768000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-185000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
34000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3847
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
41800000 USD
CY2013Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
105500000 USD
CY2013Q3 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
39600000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-60801000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-9829000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.03
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.10
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.29
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.17
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
183000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-51200000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14072000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21904000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
77333000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
84238000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
204000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1409000 USD
CY2012Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
169000 USD
CY2013Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-27793000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-38691000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1309000 USD
us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
-8688000 USD
us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
0 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
10953000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-56000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2012Q4 us-gaap Goodwill
Goodwill
80450000 USD
CY2013Q3 us-gaap Goodwill
Goodwill
222340000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-89797000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-57911000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9489000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-27130000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-28683000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-99916000 USD
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
183000 USD
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0
CY2012Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-468000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7861000 USD
CY2013Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1600000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1464000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-128000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2258000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1290000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
89000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
515000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
316000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2303000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-331000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
724000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
184000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6928000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
459000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-952000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4443000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-525000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-77000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1312000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2081000 USD
CY2012Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
11546000 USD
CY2013Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
793312000 USD
us-gaap Interest Paid
InterestPaid
3126000 USD
us-gaap Interest Paid
InterestPaid
613000 USD
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0 USD
CY2013Q3 us-gaap Interest Payable Current
InterestPayableCurrent
925000 USD
CY2013Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
14775000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17963000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
19516000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
22261000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4923000 USD
CY2013Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4426000 USD
CY2013Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1135000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1313000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
688000 USD
CY2013Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1450000 USD
us-gaap Inventory Write Down
InventoryWriteDown
1529000 USD
us-gaap Inventory Write Down
InventoryWriteDown
1520000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
86550000 USD
CY2013Q3 us-gaap Liabilities
Liabilities
515056000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1382982000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
289830000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
52382000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
71377000 USD
CY2013Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
443679000 USD
CY2012Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
34168000 USD
CY2013Q3 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
11397000 USD
CY2012Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
15195000 USD
CY2013Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
16991000 USD
CY2013Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
14477000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
17526000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5150000 USD
CY2013Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3350000 USD
CY2012Q4 us-gaap Long Term Investments
LongTermInvestments
15636000 USD
CY2013Q3 us-gaap Long Term Investments
LongTermInvestments
24690000 USD
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 USD
CY2013Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
25004000 USD
CY2013Q3 us-gaap Minority Interest
MinorityInterest
-2801000 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
-492000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4983000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
169137000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33199000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8556000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32142000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19687000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-32142000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-19701000 USD
us-gaap Net Income Loss
NetIncomeLoss
-97607000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-9646000 USD
us-gaap Net Income Loss
NetIncomeLoss
-28500000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-59998000 USD
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-803000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2309000 USD
CY2012Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10206000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30180000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-98027000 USD
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-59998000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-38901000 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-120000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
427000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-46031000 USD
CY2013Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6755000 USD
CY2012Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
0 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Operating Expenses
OperatingExpenses
119604000 USD
us-gaap Operating Expenses
OperatingExpenses
58340000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
21164000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
39651000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9369000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-27557000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-43766000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-19010000 USD
CY2013Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5887000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6182000 USD
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
4304000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4750000 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7003000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2777000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1395000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1960000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2570000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
367000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4119000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
7500000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
4593000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5527000 USD
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
40000 USD
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
322000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1869000 USD
CY2013Q3 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
1006000 USD
CY2012Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
380000 USD
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
234762000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
34168000 USD
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
55000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2571000 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7787000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
4250000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-11628000 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
3015000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
10512000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-20528000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
13341000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2700000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
50027000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
28923000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2991000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1064000 USD
CY2013Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
420000 USD
CY2012Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
560000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1680000 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19551000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7873000 USD
CY2012Q4 us-gaap Prepaid Insurance
PrepaidInsurance
301000 USD
CY2013Q3 us-gaap Prepaid Insurance
PrepaidInsurance
843000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications and correction of an error.</font><font style="font-family:inherit;font-size:10pt;"> Certain prior year amounts in the condensed consolidated financial statements have been reclassified to conform with the 2013 presentation. Due to the acquisition of OPKO OURLab, LLC (formerly Prost-Data, Inc.), our CLIA certified laboratory business (&#8220;OURLab&#8221;) in December 2012, we changed our segment presentation to include diagnostics as a reportable segment. As a result of this change in reportable segments, we restated certain prior year amounts in the condensed consolidated financial statements to conform with the 2013 presentation. These reclassifications had no impact on our results of operations.</font></div></div>
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
170184000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1702000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5061000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
29389000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
24613000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
25016000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
631000 USD
us-gaap Profit Loss
ProfitLoss
-99916000 USD
CY2013Q3 us-gaap Profit Loss
ProfitLoss
-60801000 USD
CY2012Q3 us-gaap Profit Loss
ProfitLoss
-9646000 USD
us-gaap Profit Loss
ProfitLoss
-28500000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16526000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17027000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
810000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
11000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
26108000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
27706000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12942000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3621000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11085000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30552000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-388770000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-486377000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
11495000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
16563000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
50708000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
30051000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
30783000 USD
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
11795000 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
20641000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
75838000 USD
CY2012Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
100000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
332000 USD
CY2013Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
2770000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
9050000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13572000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17428000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39875000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7322000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3281000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7411000 USD
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
400000 USD
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1100000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4435000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
179386000 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
870727000 USD
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
867926000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
178894000 USD
CY2012Q4 us-gaap Supplies
Supplies
443000 USD
CY2013Q3 us-gaap Supplies
Supplies
839000 USD
CY2012Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
24386000 USD
CY2013Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2013Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
0 USD
CY2012Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
30595000 USD
CY2012Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
2000000 shares
CY2013Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
2000000 shares
CY2012Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1129032 shares
CY2013Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2013Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2012Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1129032 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2293056 shares
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2293056 shares
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
7457000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
7457000 USD
CY2013Q3 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
25000000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font><font style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>
CY2013Q3 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
5900000 USD
CY2012Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
5600000 USD
CY2013Q3 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
8700000 USD
CY2012Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
5500000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
336942515 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
298103882 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
360638527 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
297762469 shares
CY2013Q3 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
3543000 USD
CY2012Q4 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
50000 USD
CY2013Q3 opk Accumulated Income Loss From Equity Method Investments
AccumulatedIncomeLossFromEquityMethodInvestments
12579000 USD
CY2013Q3 opk Available For Sale Securities Gross Unrealized And Realized Gain Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedAndRealizedGainLossAccumulatedInInvestments
2708000 USD
CY2013Q3 opk Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
2184000 USD
CY2012Q4 opk Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
6725000 USD
CY2013Q3 opk Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
202000 USD
CY2012Q4 opk Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
0 USD
CY2013Q3 opk Availablefor Sale Securities Accumulated Gross Realized Gain Loss Net
AvailableforSaleSecuritiesAccumulatedGrossRealizedGainLossNet
468000 USD
CY2012Q4 opk Availablefor Sale Securities Accumulated Gross Realized Gain Loss Net
AvailableforSaleSecuritiesAccumulatedGrossRealizedGainLossNet
88000 USD
CY2013Q3 opk Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-0.19
opk Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-0.12
opk Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-0.32
CY2012Q3 opk Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-0.04
CY2012Q3 opk Business Acquisition Pro Forma Net Income Loss Availableto Common Stockholders
BusinessAcquisitionProFormaNetIncomeLossAvailabletoCommonStockholders
-16302000 USD
opk Business Acquisition Pro Forma Net Income Loss Availableto Common Stockholders
BusinessAcquisitionProFormaNetIncomeLossAvailabletoCommonStockholders
-128229000 USD
CY2013Q3 opk Business Acquisition Pro Forma Net Income Loss Availableto Common Stockholders
BusinessAcquisitionProFormaNetIncomeLossAvailabletoCommonStockholders
-75055000 USD
opk Business Acquisition Pro Forma Net Income Loss Availableto Common Stockholders
BusinessAcquisitionProFormaNetIncomeLossAvailabletoCommonStockholders
-45534000 USD
opk Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Discount Rates Increase One Percent
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfDiscountRatesIncreaseOnePercent
2000000 USD
opk Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent
800000 USD
CY2013Q3 opk Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
3695000 USD
CY2012Q4 opk Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5126000 USD
CY2012Q4 opk Business Combination Deferred Acquisition Payments Netof Discount Current
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent
6172000 USD
CY2013Q3 opk Business Combination Deferred Acquisition Payments Netof Discount Current
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent
5335000 USD
CY2013Q3 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
15 institution
CY2013Q3 opk Deferred Revenue Received From Collaboration Agreement
DeferredRevenueReceivedFromCollaborationAgreement
3400000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-27219000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-92055000 USD
CY2013Q3 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-59201000 USD
CY2012Q3 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-9361000 USD
CY2013Q3 opk Business Combination Deferred Acquisition Payments Netof Discount Noncurrent
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountNoncurrent
0 USD
CY2012Q4 opk Business Combination Deferred Acquisition Payments Netof Discount Noncurrent
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountNoncurrent
3931000 USD
CY2013Q3 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
1100000000 USD
CY2012Q4 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
200000000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
7000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
815000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
10148000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
975000 USD
CY2012Q3 opk Interest Expense Nonoperating
InterestExpenseNonoperating
393000 USD
CY2013Q3 opk Interest Expense Nonoperating
InterestExpenseNonoperating
3409000 USD
CY2013Q3 opk Interest Income Nonoperating
InterestIncomeNonoperating
88000 USD
CY2012Q3 opk Interest Income Nonoperating
InterestIncomeNonoperating
49000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
123000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
237000 USD
CY2012Q3 opk Numberof Medicare Claims Includedin Post Payment Review Audit
NumberofMedicareClaimsIncludedinPostPaymentReviewAudit
183 claim
opk Revenue From Receipt Of Equity
RevenueFromReceiptOfEquity
12680000 USD
opk Revenue From Receipt Of Equity
RevenueFromReceiptOfEquity
159000 USD
opk Revenue From Sale Of Intellectual Property
RevenueFromSaleOfIntellectualProperty
12500000 USD
opk Revenue From Sale Of Intellectual Property
RevenueFromSaleOfIntellectualProperty
0 USD
CY2012Q3 opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
200000 USD
CY2013Q3 opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
1308000 USD
opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
400000 USD
opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
16080000 USD
opk Revenue Received From Collaboration Agreement Offsetto Researchand Development
RevenueReceivedFromCollaborationAgreementOffsettoResearchandDevelopment
700000 USD
CY2013Q3 opk Revenue Received From Collaboration Agreement Offsetto Researchand Development
RevenueReceivedFromCollaborationAgreementOffsettoResearchandDevelopment
400000 USD
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
1379 shares
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
115514 shares
CY2012Q3 opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
853 shares
CY2012Q3 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
161264 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
750162 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
4933976 shares
CY2013Q3 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
3206230 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
748783 shares
CY2012Q3 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
160411 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
4818462 shares
opk Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
-626000 USD
CY2013Q3 opk Taxes Recoverable Current
TaxesRecoverableCurrent
2992000 USD
CY2012Q4 opk Taxes Recoverable Current
TaxesRecoverableCurrent
1493000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000944809
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
407989487 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Opko Health, Inc.

Files In Submission

Name View Source Status
0000944809-13-000009-index-headers.html Edgar Link pending
0000944809-13-000009-index.html Edgar Link pending
0000944809-13-000009.txt Edgar Link pending
0000944809-13-000009-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
opk-09302013xex31.htm Edgar Link pending
opk-20130930.xml Edgar Link completed
opk-20130930.xsd Edgar Link pending
opk-20130930_cal.xml Edgar Link unprocessable
opk-20130930_def.xml Edgar Link unprocessable
opk-20130930_lab.xml Edgar Link unprocessable
opk-20130930_pre.xml Edgar Link unprocessable
opk-9302013x10q.htm Edgar Link pending
opk-9302013xex311.htm Edgar Link pending
opk-9302013xex312.htm Edgar Link pending
opk-9302013xex321.htm Edgar Link pending
opk-9302013xex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending